Gates MRI looks to Phase 3 TB vaccine trial with epidemiology study

The Bill & Melinda Gates Medical Research Institute (MRI) is conducting a TB epidemiology study: setting the stage for a Phase 3 efficacy trial for its investigational TB vaccine.

Read the full story at BioPharma-Reporter.com.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Rachel Arthur

Published: April 5, 2022, 3:15 p.m.

Last updated: April 5, 2022, 11:18 p.m.

Print Share